Back to Results
First PageMeta Content
Smoking cessation / Tobacco / Smoking / Monoamine oxidase inhibitors / Addiction / Nicotine replacement therapy / Electronic cigarette / Nicorette / PSE / Ethics / Medicine / Pharmacology


National Drug Strategy 2010 – 2015 Submission for consideration by Johnson & Johnson Pacific (JJP) 24th February 2010
Add to Reading List

Document Date: 2011-07-07 22:12:10

Open Document

File Size: 85,50 KB

Share Result on Facebook

Company

Johnson & Johnson / PSE / /

Country

Australia / United Kingdom / /

Event

Security Buyback / /

Facility

Pharmacy Medicine / Pharmacy Guild / Cancer Institute of NSW / pharmacy Address / /

IndustryTerm

flu products / web-based real time recording system / web-based recording system / pseudoephedrine based decongestant products / unlicensed nicotine-containing products / chemical diversion / WEB-based real time / real time recording program / law enforcement / real time web / unlicensed nicotine containing products / oral decongestant products / beauty products / /

Organization

Cancer Institute of NSW / Pharmacy Guild / Medicines and Healthcare Products Regulatory Agency / /

/

Position

runner / Governor / Pharmacist / leader in the development / /

ProvinceOrState

Prince Edward Island / /

URL

http /

SocialTag